Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C

Liver International

Volumn 28, Issue 10, 2008, Pages 1352-1362

  Calès, Paul ^a   De Ledinghen, Victor ^b   Halfon, Philippe ^c   Bacq, Yannick ^d   Leroy, Vincent ^e   Boursier, Jérôme ^a   Foucher, Juliette ^b   Bourlière, Marc ^f   De Muret, Anne ^d   Sturm, Nathalie ^e   Hunault, Gilles ^a   Oberti, Frédéric ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c Laboratoire Alphabio   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f HÔPITAL SAINT JOSEPH   (France)

Author keywords

Blood test; Diagnostic accuracy; Liver biopsy; Liver fibrosis; Metavir staging; Non invasive diagnosis; Reliable diagnosis; Sensitivity; Specificity; Viral hepatitis C

Indexed keywords

ADULT; AREA UNDER THE RECEIVER OPERATING CHARACTERISTIC CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE MISCLASSIFICATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METAVIR F STAGE; NEGATIVE PREDICTIVE VALUE; POSITIVE PREDICTIVE VALUE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STAGING; THROMBOCYTE COUNT;

ADULT; BIOPSY; FEMALE; HEMATOLOGIC TESTS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 54049099217     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01789.x     Document Type: Article

References (25)

1. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 1609-16.
2. Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12: 3682-94.
3. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet 2001; 357: 1069-75.
4. Leroy V, Hilleret MN, Sturm N, et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007; 46: 775-82.
5. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
6. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-6.
7. Adams LA, Bulsara M, Rossi E, et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 1867-73.
8. Cales P, Oberti F, Michalak S, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-81.
9. Halfon P, Bacq Y, De Muret A, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2007; 46: 395-402.
10. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
11. Calès P, Halfon P, Bacq Y, et al. Meta-analysis of blood scores for liver fibrosis in chronic hepatitis C. Hepatology 2006; 44: 279A.
12. Cales P, Veillon P, Konate A, et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem 2008; 41: 10-8.
13. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15-20.
14. Rousselet MC, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.
15. Greenhalgh T. How to read a paper. Papers that report diagnostic or screening tests. Br Med J 1997; 315: 540-3.
16. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: A single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35.
17. Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 462-74.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44: 837-45.
19. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic acuracy: Explanation and elaboration. Clin Chem 2003; 49: 7-18.
20. Calès P, Halfon P, Bacq Y, et al. Fibrosis stages determination, reproducibility and robustness of blood tests for liver fibrosis in chronic hepatitis C. Hepatology 2007; 46: 846A.
21. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-45.
22. Poynard T, Munteanu M, Ngo Y, Torres M, Benhamou YDT. Diagnostic value of fibrotest with normal serum aminotransferases. Hepatology 2006; 43: 374-5.
23. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
24. Calès P, Boursier J, Rousselet M, et al. Comparison of reproducibility of histology, blood tests and Fibroscan for liver fibrosis. Hepatology 2007; 46: 834A.
25. Sebastiani G, Vario A, Guido M, et al. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 686-93.